Tuhura Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.45

-0.07 (-4.61%)

As of Nov 14, 2:38 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +859.3% upside

Low Target $12.64

Average Target $13.91

High Target $18.47

Current Price $1.45

Current
$1.45

Target
$13.91

$12.64 $13.91 avg $18.47

Scenario Analysis

Bear Case

$12.64

771.7%

Low target

Base Case

$13.91

+859.3%

Avg target

Bull Case

$18.47

+1,173.8%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$3.43

-57.7% from high

52-Week Low

$0.41

+253.7% from low

Target vs 52W High

$13.91

+305.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%